Women's Health: The Market for Menopause, Fertility and Contraceptive Drugs

Attention: There is an updated edition available for this report.
 
Online Download $350
Special Offer: Now 35% off original sale price of $3250
This up-to-date report examines the current market for menopause, fertility and contraceptive drugs in an ever-changing world. The report focuses on trends, new developments, consumer preferences and product demand patterns that shape this market. The report's detailed market analysis includes historical, current and forecast revenues for each of the product markets. This report projects annual revenue through 2004, examines growth factors, provides in-depth analysis of new products in the research and development stage and includes profiles of major competitors in each market segment.

Chapter One: Executive Summary

  • Introduction
  • Scope and Methodology
  • Size and Growth of the Market
  • Trends Affecting the Market
  • Industry Structure and Leading Competitors
  • The Consumer

Chapter Two: Introduction

  • Scope and Methodology
  • The Female Reproductive System
    • Female Reproductive Organs
    • The Menstrual Cycle and Role of Hormones
    • Conception and the Role of Hormones
  • Menopause
    • Definition
    • Premenopause
    • Menopause
    • Postmenopause
      • Heart Disease
        • Risk Factors
        • Mortality
        • Prevention
        Osteoporosis
        • Definition
        • Bone Production
        • Risk Factors
        • Prevalence
        • Cost
        • Prevention
  • Infertility
    • Definition
    • Causes
      • Endometriosis
        • Definition
        • Symptoms
        • Causes
        • Infertility and Endometriosis
      • Hormonal Imbalances
        • Amenorrhea
        • Anovulation
        • Luteal Phase Dysfunction
  • Contraception
    • Definition
    • Barrier Methods
    • Intrauterine Devices
    • Surgical Methods
    • Drugs

Chapter Three: Menopause

  • Overview
    • Cardiovascular Disease
    • Uterine and Breast Cancers
      • The PEPI Trial
      • The HERS Study
      • The EPIC Study
      • FIT..
  • Menopause Therapies
    • Hormonal Therapies
      • Estrogen Replacement Therapy
      • Hormone Replacement Therapy
    • Nonhormonal Therapies
      • Bisphosphonates
      • Calcitonin
      • Selective Estrogen Receptor Modulators
    • Menopausal Vasomotor Symptom Drugs
    • Osteoporosis Drugs
    • Drug Formulations
      • Oral
      • Creams
      • Transdermal
      • Vaginal Ring
      • Inhaler
    • New Drugs
      • Esclim
      • Cenestin
      • Combi-Patch
    • Menopause Drugs in Development
      • Trimegestone
    • Osteoporosis Drugs in Development
    • New Formulations of Existing Drugs
      • Low-Dose Climara
      • Vivelle-Dot
  • Hormone Replacement Therapy: Issues and Trends
    • Increasing Life Span of Postmenopausal Women
    • Number of Women Using HRT
    • Cancer Risk and Consumers' Fears
    • Women's Health Initiative
    • Oral Versus Transdermal Formulations
    • Side Effects
    • Selective Estrogen Receptor Modulators: "Designer Estrogen"
    • Vitamins, Nutritional Supplements, and Herbs
      • Calcium
      • Magnesium
      • Vitamin E
      • Phytoestrogens
      • Soy Supplements
  • Leading Products
    • Premarin Family
    • Fosamax
    • Miacalcin
    • Estraderm
    • Evista
    • Climara
    • Provera
    • Estrace
  • Market Size and Forecast
  • Competitor Analysis
    • Wyeth-Ayerst
    • Merck
    • Novartis
    • Eli Lilly
    • Pharmacia & Upjohn
    • Bristol-Myers Squibb
  • Market Analysis

Chapter Four: Fertility

  • Overview and History of Development
  • Endometriosis Drugs
    • GnRH Inhibitors
      • Danazol
      • GnRH Analogs
        • Goserelin Acetate
        • Leuprolide Acetate
        • Nafarelin Acetate
    • Progestins
    • Endometriosis Drugs in Development
  • Fertility Drugs
    • Drugs Used to Treat Hormonal Imbalances
      • Clomiphene Citrate
      • Follitropin Alfa
      • Follitropin Beta
      • Chorionic Gonadotropin
      • Menotropins
      • Urofollitropin
    • Progesterone Deficiency
    • Prolactin Inhibitor
    • Drugs Used in Assisted Conception
      • Gonadotropins
      • GnRH Agonists
    • Infertility Drugs in Development
  • Issues and Trends in Infertility
    • Number of Couples Seeking Treatment
    • Assisted Reproductive Technologies
      • Costs
      • Multiple Births
      • Fetal Reduction
      • Frozen Embryos
      • Regulation of Fertility Clinics
      • Potential Increase in Cancer Incidence
  • Market Size and Forecast
  • Competitor Analysis
    • Ares-Serono
    • Organon
    • Ferring Pharmaceuticals
    • Aventis Pharma
    • Novartis
  • Market Analysis

Chapter Five: Contraceptives

  • Overview
  • Products
    • Oral Contraceptives
      • The Combined Pill
        • Components
        • Mechanism of Action
        • Types of Combined Pill
      • The Progestin-Only Pill
      • Third-Generation Oral Contraceptives
      • Side Effects
    • Contraceptive Implants
    • Contraceptive Injections
    • Contraceptive Drugs in Development
      • Overview
      • Depo-Provera Once-a-Month Injection
      • Implanon
      • Seasonale
      • Vaginal Ring
      • Yasmin
  • Issues and Trends in Contraception
    • Long-Term Research on the Safety of Oral Contraceptives
    • Contraceptive Costs
    • Return of the Today Sponge
    • Norplant Problems
    • Discontinuance of Norplant in the United Kingdom
    • Male Contraceptives
    • Emergency Contraceptive Kit—Preven
  • Market Size and Forecast
    • Monophasic Oral Contraceptives
    • Biphasic Oral Contraceptives
    • Triphasic Oral Contraceptives
    • Estrophasic Oral Contraceptives
    • Progestin-Only Oral Contraceptives
    • Trends in Product Development
  • Competitor Analysis
    • Johnson & Johnson
    • Organon
    • Berlex
    • Parke-Davis
    • Pharmacia & Upjohn
    • Bristol-Myers Squibb
    • Searle
    • Watson
    • Wyeth-Ayerst
  • Market Analysis

Chapter Six: Issues and Trends

  • Demographics
    • Female Population by Age Group
    • Menopause Age Group
    • Infertility Age Group
    • Contraceptive Age Group
      • Number of Pregnancies Per Year
      • Percentage of Female Population Using Contraceptives
  • Women in Drug Trials
  • Women's Health Drugs in Development
  • Insurance and Managed Care
    • Growth of Managed Care
    • Impact of Managed Care on the Pharmaceutical Industry
    • Generic Versus Brand-Name Products
    • Impact on Women's Health
    • Insurance Company Reimbursement
      • Menopause Drugs
        • Medicare Reimbursement
        • Medicare Reform
      • Fertility Drugs
      • Contraceptives
        • Legislation
        • Prescription Versus OTC
  • Medical Abortion Drug
    • Safety and Efficacy
    • Legislation

Chapter Seven: Market Summary

  • Scope and Methodology
  • Industry Structure
    • Mergers and Acquisitions
      • Abbott and Alza
      • Astra and Zeneca
      • Hoechst and Rhone-Poulenc
      • Sanofi and Synthelabo
    • Direct-to-Consumer Advertising
    • The Internet
    • Marketing Challenges
  • Market Size and Forecast
    • Menopause Drugs
    • Fertility Drugs
    • Contraceptive Drugs

Chapter Eight: Competitor Profiles

  • American Home Products Corporation
    • History and Lines of Business
    • Women's Health Drugs
    • Financial Information
    • Corporate Strategies
  • The Ares-Serono Group
    • History and Lines of Business
    • Women's Health Drugs
    • Financial Information
    • Corporate Strategies
  • Aventis SA
    • History and Lines of Business
    • Women's Health Drugs
    • Financial Information
    • Corporate Strategies
  • Berlex Laboratories
    • History and Lines of Business
    • Women's Health Drugs
    • Financial Information
    • Corporate Strategies
  • Bristol-Myers Squibb Company
    • History and Lines of Business
    • Women's Health Drugs
    • Financial Information
    • Corporate Strategies
  • G. D. Searle & Company
    • History and Lines of Business
    • Women's Health Drugs
    • Financial Information
    • Corporate Strategies
  • Johnson & Johnson
    • History and Lines of Business
    • Women's Health Drugs
    • Financial Information
    • Corporate Strategies
  • Merck & Company, Inc.
    • History and Lines of Business
    • Women's Health Drugs
    • Financial Information
    • Corporate Strategies
  • Novartis International AG
    • History and Lines of Business
    • Women's Health Drugs
    • Financial Information
    • Corporate Strategies
  • Organon, Inc.
    • History and Lines of Business
    • Women's Health Drugs
    • Financial Information
    • Corporate Strategies
  • Parke-Davis
    • History and Lines of Business
    • Women's Health Drugs
    • Financial Information
    • Corporate Strategies
  • Pharmacia & Upjohn, Inc.
    • History and Lines of Business
    • Women's Health Drugs
    • Financial Information
    • Corporate Strategies
  • Searle, G. D. & Company - see G.D. Searle & Company Solvay SA
    • History and Lines of Business
    • Women's Health Drugs
    • Financial Information
    • Corporate Strategies
  • TAP Holdings Inc.
    • History and Lines of Business
    • Women's Health Drugs
    • Financial Information
    • Corporate Strategies
  • Appendix: Company Names and Addresses

In this report, {{keyword[keywordTextProperty]}} appears {{keyword[keywordCountProperty]}} times. {{searchResults.STATRESULT.SUMMARY.KW[keywordTextProperty]}} appears {{searchResults.STATRESULT.SUMMARY.KW[keywordCountProperty]}} times.

We were unable to search inside this report.

Search for an exact word or phrase by placing the word or phrase in quotation marks ("market trend"). Search for different versions or tenses of a word by placing an asterisk at the end of the word (pharma*).

Please note that your term must be at least three characters long and numbers will be blocked by the # sign.